FDA inspection
Livzon New North River Pharmaceutical Co., Ltd.: FDA inspection ending Jul 16, 2009
FDA inspection 604389 · Official Action Indicated (OAI) · Qingyuan
Key facts
| Inspection ID | 604389 |
|---|---|
| Firm | Livzon New North River Pharmaceutical Co., Ltd. |
| FEI number | 3005619530 |
| Address | Renmin One Road |
| City | Qingyuan |
| Country | China |
| Fiscal year | 2009 |
| Inspection end date | Jul 16, 2009 |
| Classification | Official Action Indicated (OAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data